In line with these findings, the use of lapatinib, a dual-EGFR and HER2 inhibitor, decreased the ACTH levels and inhibited the cell proliferation of the AtT-20 mouse corticotroph tumor cells [174]. This evidence concerns the gene POMC and neoplasm.